Treats infections caused by susceptible strains of the designated organisms in theโฆ. ANDA 61147, held by Strides Pharma Intl. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 61147 (Sumycin), held by Strides Pharma Intl, was first approved by FDA on Feb 10, 1971, with 9 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 10, 1971 | Original application | Approved | None posted |
| Sumycin250MG ยท tablet;oral | Tetracycline Hydrochloride | Rx |
| Sumycin100MG ยท tablet;oral | Tetracycline Hydrochloride | Discontinued |
| Sumycin50MG ยท tablet;oral | Tetracycline Hydrochloride | Discontinued |
| Sumycin500MG ยท tablet;oral | Tetracycline Hydrochloride | Rx |
| Mar 31, 2025 | Supplement 28Labeling ยท Standard review | Approved | None posted |
| May 25, 2017 | Supplement 26Manufacturing | Approved | None posted |
| Sep 30, 2004 | Supplement 25Labeling | Approved | None posted |
| Jul 22, 1997 | Supplement 16Labeling | Approved | None posted |
| Nov 9, 1995 | Supplement 23Manufacturing | Approved | None posted |
| Jun 30, 1994 | Supplement 22Manufacturing | Approved | None posted |
| Dec 24, 1992 | Supplement 21Labeling | Approved | None posted |
| Jul 3, 1991 | Supplement 19Manufacturing | Approved | None posted |
| Feb 23, 1991 | Supplement 18Manufacturing | Approved | None posted |
| Feb 10, 1971 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters